Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1056)
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
102
Price
$155.59
Total Value
$15.87K
Shares Held After
302
% of Holdings
25.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
400
Price
$153.00
Total Value
$61.20K
Shares Held After
404
% of Holdings
49.8%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,998
Price
$151.80
Total Value
$303.29K
Shares Held After
804
% of Holdings
71.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,500
Price
$151.39
Total Value
$227.08K
Shares Held After
2,802
% of Holdings
34.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
100
Price
$85.65
Total Value
$8.56K
Shares Held After
505,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,800
Price
$84.69
Total Value
$152.44K
Shares Held After
505,786
% of Holdings
0.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,100
Price
$83.86
Total Value
$679.26K
Shares Held After
507,586
% of Holdings
1.6%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,700
Price
$0.35
Total Value
$945.00
Shares Held After
36,899
% of Holdings
7.3%
Phio Pharmaceuticals Corp. (PHIO)
Plott Ronald Todd — Director
Shares
15,000
Price
$1.14
Total Value
$17.10K
Shares Held After
15,000
% of Holdings
100.0%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
50,000
Price
$74.06
Total Value
$3.70M
Shares Held After
142,265
% of Holdings
26.0%
Camp4 Therapeutics Corp (CAMP)
Tardiff Daniel — Chief Scientific Officer
Shares
1,738
Price
$4.76
Total Value
$8.27K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,200
Price
$107.77
Total Value
$344.85K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,600
Price
$107.22
Total Value
$1.03M
Shares Held After
770,980
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,200
Price
$106.36
Total Value
$765.78K
Shares Held After
780,580
% of Holdings
0.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
30,918
Price
$1.65
Total Value
$50.89K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
31,000
Price
$1.65
Total Value
$51.03K
Shares Held After
48,750
% of Holdings
38.9%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,892
Price
$18.19
Total Value
$88.99K
Shares Held After
77,786
% of Holdings
5.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
2,778
Price
$117.55
Total Value
$326.55K
Shares Held After
0
% of Holdings
100.0%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
12,757
Price
$5.49
Total Value
$70.00K
Shares Held After
13,705
% of Holdings
93.1%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
186
Price
$71.98
Total Value
$13.39K
Shares Held After
9,570
% of Holdings
1.9%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
418
Price
$71.98
Total Value
$30.09K
Shares Held After
54,627
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,664
Price
$24.41
Total Value
$382.36K
Shares Held After
46,683
% of Holdings
25.1%
Adaptive Biotechnologies Corp (ADPT)
HERSHBERG ROBERT — Director
Shares
15,000
Price
$24.39
Total Value
$365.85K
Shares Held After
62,347
% of Holdings
19.4%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Skye Bioscience, Inc. (SKYE)
5AM Partners VII, LLC — 10% Owner
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
253,080
Price
$0.38
Total Value
$96.17K
Shares Held After
7,914,126
% of Holdings
3.1%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
1,830
Price
$0.38
Total Value
$695.40
Shares Held After
55,663
% of Holdings
3.2%
Skye Bioscience, Inc. (SKYE)
Schwab Andrew J. — Director
Shares
45,090
Price
$0.38
Total Value
$17.13K
Shares Held After
1,411,974
% of Holdings
3.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
OLUKOTUN ADEOYE Y — Director
Shares
2,000
Price
$86.96
Total Value
$173.92K
Shares Held After
31,600
% of Holdings
6.0%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,293
Price
$3.38
Total Value
$7.75K
Shares Held After
1,056,594
% of Holdings
0.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
PERRY MICHAEL S — Director
Shares
11,600
Price
$87.30
Total Value
$1.01M
Shares Held After
111,459
% of Holdings
9.4%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
631
Price
$3.38
Total Value
$2.13K
Shares Held After
673,853
% of Holdings
0.1%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
185
Price
$2.01
Total Value
$371.85
Shares Held After
82,009
% of Holdings
0.2%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
484
Price
$2.01
Total Value
$972.84
Shares Held After
385,859
% of Holdings
0.1%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
1,229
Price
$2.01
Total Value
$2.47K
Shares Held After
2,244,088
% of Holdings
0.1%
Keros Therapeutics, Inc. (KROS)
Lerner Lorena Raquel — Chief Scientific Officer
Shares
3,568
Price
$10.29
Total Value
$36.71K
Shares Held After
27,559
% of Holdings
11.5%
Acrivon Therapeutics, Inc. (ACRV)
Devroe Eric — Chief Operating Officer
Shares
604
Price
$2.01
Total Value
$1.21K
Shares Held After
146,349
% of Holdings
0.4%
Acrivon Therapeutics, Inc. (ACRV)
Gamelin Erick — Chief Development Officer
Shares
400
Price
$2.01
Total Value
$804.00
Shares Held After
52,592
% of Holdings
0.8%
Keros Therapeutics, Inc. (KROS)
Newton Charles W. — Director
Shares
551
Price
$10.30
Total Value
$5.68K
Shares Held After
12,114
% of Holdings
4.4%
Keros Therapeutics, Inc. (KROS)
Tanini Annita — Corp. Controller&VP, Finance
Shares
1,224
Price
$10.29
Total Value
$12.59K
Shares Held After
45,144
% of Holdings
2.6%
Keros Therapeutics, Inc. (KROS)
Cho Esther — Chief Legal Officer
Shares
4,485
Price
$10.29
Total Value
$46.15K
Shares Held After
35,770
% of Holdings
11.1%
Acrivon Therapeutics, Inc. (ACRV)
Peterson Katharine — Chief Accounting Officer
Shares
101
Price
$2.01
Total Value
$203.01
Shares Held After
18,033
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
400
Price
$119.64
Total Value
$47.86K
Shares Held After
1,133,539
% of Holdings
0.0%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
7,055
Price
$118.88
Total Value
$838.71K
Shares Held After
1,133,939
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
91,167
Price
$118.24
Total Value
$10.78M
Shares Held After
1,140,994
% of Holdings
7.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,199
Price
$83.77
Total Value
$100.44K
Shares Held After
243,327
% of Holdings
0.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,602
Price
$82.99
Total Value
$1.21M
Shares Held After
244,526
% of Holdings
5.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
17,279
Price
$82.21
Total Value
$1.42M
Shares Held After
259,128
% of Holdings
6.3%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
4,984
Price
$117.47
Total Value
$585.48K
Shares Held After
1,232,161
% of Holdings
0.4%
Showing 101–150 of 1056 transactions (page 3 of 22)